hCINAP negatively regulates NF-κB signaling by recruiting the phosphatase PP1 to deactivate IKK complex

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Nuclear factor-κB (NF-κB) signaling is crucial for immune homeostasis and is tightly regulated.
• The molecular mechanisms underlying NF-κB negative regulation are not fully understood.
• Understanding NF-κB regulation is vital for addressing inflammatory diseases.

Purpose of the Study:

• To identify novel negative regulators of NF-κB signaling.
• To elucidate the molecular mechanisms of NF-κB deactivation.
• To investigate the role of human coilin-interacting nuclear ATPase protein (hCINAP) in NF-κB regulation.

Main Methods:

• Investigated the interaction of hCINAP with IκB kinase (IKK) complex components (IKKα and IKKβ) upon TNF stimulation.
• Assessed the effect of hCINAP on IKK phosphorylation.
• Examined the interaction of hCINAP with protein phosphatase 1 (PP1) and its role in forming the IKK-hCINAP-PP1 complex.
• Analyzed hCINAP levels in inflammatory diseases associated with NF-κB hyperactivity.

Main Results:

• hCINAP functions as a novel negative regulator of NF-κB signaling.
• hCINAP deactivates the IKK complex by inhibiting IKK phosphorylation.
• hCINAP acts as an adaptor protein, recruiting PP1 to dephosphorylate IKK.
• Reduced hCINAP levels correlate with NF-κB hyperactivity in inflammatory diseases.

Conclusions:

• hCINAP deactivates IKK, providing a novel mechanism for negative regulation of NF-κB signaling.
• This discovery offers new insights into maintaining immune homeostasis and potential therapeutic targets for inflammatory conditions.
• hCINAP's role highlights the importance of understanding negative feedback loops in immune signaling pathways.